BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38531859)

  • 1. Nuclear receptor NURR1 functions to promote stemness and epithelial-mesenchymal transition in prostate cancer via its targeting of Wnt/β-catenin signaling pathway.
    Zhang X; Li H; Wang Y; Zhao H; Wang Z; Chan FL
    Cell Death Dis; 2024 Mar; 15(3):234. PubMed ID: 38531859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.
    Li J; Karki A; Hodges KB; Ahmad N; Zoubeidi A; Strebhardt K; Ratliff TL; Konieczny SF; Liu X
    Mol Cell Biol; 2015 Dec; 35(24):4185-98. PubMed ID: 26438599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
    Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
    Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
    Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
    Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metastasis suppressor CD82/KAI1 represses the TGF-β
    Lee MS; Lee J; Kim YM; Lee H
    Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.
    Zhang L; Cen L; Qu S; Wei L; Mo M; Feng J; Sun C; Xiao Y; Luo Q; Li S; Yang X; Xu P
    PLoS One; 2016; 11(4):e0152931. PubMed ID: 27045591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-ionone Inhibits Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Cells by Negatively Regulating the Wnt/β-Catenin Pathway.
    Fang Q; Que T; Liu B; Dan W; Wei Y; Ren B; Fan Y; Hou T; Zeng J
    Front Biosci (Landmark Ed); 2022 Dec; 27(12):335. PubMed ID: 36624947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
    Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
    J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the Wnt/β-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer.
    Zhang Z; Cheng L; Li J; Farah E; Atallah NM; Pascuzzi PE; Gupta S; Liu X
    Cancer Res; 2018 Jun; 78(12):3147-3162. PubMed ID: 29700003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC15 loss facilitates epithelial-mesenchymal transition and cancer stemness for prostate cancer metastasis through GSK3β/β-catenin signaling.
    Wu S; Yue Y; Gu Y; Wang Q; Liu T; Li L; Wang X; Chang LS; He D; Wu K
    Cell Signal; 2021 Aug; 84():110015. PubMed ID: 33894313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRKAR2B promotes prostate cancer metastasis by activating Wnt/β-catenin and inducing epithelial-mesenchymal transition.
    Sha J; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W
    J Cell Biochem; 2018 Sep; 119(9):7319-7327. PubMed ID: 29761841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells.
    Gao W; Wang Y; Yu S; Wang Z; Ma T; Chan AM; Chiu PK; Ng CF; Wu D; Chan FL
    Stem Cell Res Ther; 2022 May; 13(1):188. PubMed ID: 35526071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin-driven EMT regulation in human cancers.
    Xue W; Yang L; Chen C; Ashrafizadeh M; Tian Y; Sun R
    Cell Mol Life Sci; 2024 Feb; 81(1):79. PubMed ID: 38334836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
    Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
    Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer.
    Ma F; Arai S; Wang K; Calagua C; Yuan AR; Poluben L; Gu Z; Russo JW; Einstein DJ; Ye H; He MX; Liu Y; Van Allen E; Sowalsky AG; Bhasin MK; Yuan X; Balk SP
    Cancer Res; 2022 Apr; 82(8):1518-1533. PubMed ID: 35131873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer.
    Patel R; Brzezinska EA; Repiscak P; Ahmad I; Mui E; Gao M; Blomme A; Harle V; Tan EH; Malviya G; Mrowinska A; Loveridge CJ; Rushworth LK; Edwards J; Ntala C; Nixon C; Hedley A; Mackay G; Tardito S; Sansom OJ; Leung HY
    Cancer Res; 2020 Feb; 80(3):576-590. PubMed ID: 31719098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
    Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
    World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
    Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
    Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.